SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-121868
Filing Date
2016-05-18
Accepted
2016-05-18 16:09:49
Documents
13
Period of Report
2016-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-11454_18k.htm 8-K 27979
2 EX-99.1 a16-11454_1ex99d1.htm EX-99.1 14848
3 EX-99.2 a16-11454_1ex99d2.htm EX-99.2 10814
4 EX-99.3 a16-11454_1ex99d3.htm EX-99.3 11754
5 EX-99.4 a16-11454_1ex99d4.htm EX-99.4 68034
6 EX-99.5 a16-11454_1ex99d5.htm EX-99.5 55361
7 GRAPHIC g114541mmi001.jpg GRAPHIC 293873
8 GRAPHIC g114541moi001.jpg GRAPHIC 289150
9 GRAPHIC g114541mui001.jpg GRAPHIC 1946
10 GRAPHIC g114541mui002.jpg GRAPHIC 1867
11 GRAPHIC g114541msi001.jpg GRAPHIC 1946
12 GRAPHIC g114541msi002.jpg GRAPHIC 1867
13 GRAPHIC g114541mqi001.jpg GRAPHIC 300706
  Complete submission text file 0001104659-16-121868.txt   1418489
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 161660573
SIC: 2834 Pharmaceutical Preparations